Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2

被引:24
作者
Johnson, Kyle B. [1 ]
Petersen-Jones, Humphrey [1 ]
Thompson, Janice M. [1 ]
Hitomi, Kiyotaka [2 ]
Itoh, Miho [2 ]
Bakker, Erik N. T. P. [3 ]
Johnson, Gail V. W. [4 ]
Colak, Gozde [4 ]
Watts, Stephanie W. [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
[2] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan
[3] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Rochester, Dept Anesthesiol, Rochester, NY USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2012年 / 302卷 / 07期
关键词
protein cross-linking; amidation; vascular disease; TISSUE TRANSGLUTAMINASE; FACTOR-XIII; CROSS-LINKING; SEROTONYLATION; STABILIZATION; DEFICIENT; CYSTAMINE; SYSTEM; MICE;
D O I
10.1152/ajpheart.00918.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Johnson KB, Petersen-Jones H, Thompson JM, Hitomi K, Itoh M, Bakker ENTP, Johnson GV, Colak G, Watts SW. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. Am J Physiol Heart Circ Physiol 302: H1355-H1366, 2012. First published February 3, 2012; doi: 10.1152/ajpheart.00918.2011.-Transglutaminase (TG) function facilitates several vascular processes and diseases. Although many of these TG-dependent vascular processes have been ascribed to the function of TG2, TG2 knockout mice have a mild vascular phenotype. We hypothesized that TGs besides TG2 exist and function in the vasculature. Biotin-pentylamide incorporation, a measure of general TG activity, was similar in wild-type and TG2 knockout mouse aortae, and the general TG inhibitor cystamine reduced biotin-pentylamine incorporation to a greater extent than the TG2-specific inhibitor Z-DON, indicating the presence of other functional TGs. Additionally, 5-hydroxytryptamine-induced aortic contraction, a TG-activity-dependent process, was decreased to a greater extent by general TG inhibitors vs. Z-DON (maximum contraction: cystamine = abolished, monodansylcadaverine = 28.6 +/- 14.9%, and Z-DON = 60.2 +/- 15.2% vehicle), providing evidence for the importance of TG2-independent activity in the vasculature. TG1, TG2, TG4, and Factor XIII (FXIII) mRNA in rat aortae and vena cavae was detected by RT-PCR. Western analysis detected TG1 and TG4, but not FXIII, in rat aortae and vena cavae and in TG2 knockout and wild-type mouse aortae. Immunostaining confirmed the presence of TG1, TG2, and TG4 in rat aortae and vena cavae, notably in smooth muscle cells; FXIII was absent. K5 and T26, FITC-labeled peptide substrates specific for active TG1 and TG2, respectively, were incorporated into rat aortae and vena cavae and wild-type, but not TG2 knockout, mouse aortae. These studies demonstrate that TG2-independent TG activity exists in the vasculature and that TG1 and TG4 are expressed in vascular tissues.
引用
收藏
页码:H1355 / H1366
页数:12
相关论文
共 39 条
[21]   Novel aspects of blood coagulation factor XIII .1. Structure, distribution, activation, and function [J].
Muszbek, L ;
Adany, R ;
Mikkola, H .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1996, 33 (05) :357-421
[22]   Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction [J].
Nahrendorf, M ;
Hu, K ;
Frantz, S ;
Jaffer, FA ;
Tung, CH ;
Hiller, KH ;
Voll, S ;
Nordbeck, P ;
Sosnovik, D ;
Gattenlöhner, S ;
Novikov, M ;
Dickneite, G ;
Reed, GL ;
Jakob, P ;
Rosenzweig, A ;
Bauer, WR ;
Weissleder, R ;
Ertl, G .
CIRCULATION, 2006, 113 (09) :1196-1202
[23]   Targeted inactivation of Gh/tissue transglutaminase II [J].
Nanda, N ;
Iismaa, SE ;
Owens, WA ;
Husain, A ;
Mackay, F ;
Graham, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20673-20678
[24]   The existence of a local 5-hydroxytryptaminergic system in peripheral arteries [J].
Ni, W. ;
Geddes, T. J. ;
Priestley, J. R. C. ;
Szasz, T. ;
Kuhn, D. M. ;
Watts, S. W. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (03) :663-674
[25]   CROSS-LINK IN FIBRIN POLYMERIZED BY FACTOR 13 EPSILON-(GAMMA-GLUTAMYL)LYSINE [J].
PISANO, JJ ;
FINLAYSON, JS ;
PEYTON, MP .
SCIENCE, 1968, 160 (3830) :892-+
[26]  
Rasband WS, 1997, ImageJ
[27]   Roles of transglutaminases in cardiac and vascular diseases [J].
Sane, David C. ;
Kontos, Jimmy L. ;
Greenberg, Charles S. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :2530-2545
[28]   A Profiling Platform for the Characterization of Transglutaminase 2 (TG2) Inhibitors [J].
Schaertl, Sabine ;
Prime, Michael ;
Wityak, John ;
Dominguez, Celia ;
Munoz-Sanjuan, Ignacio ;
Pacifici, Robert E. ;
Courtney, Stephen ;
Scheel, Andreas ;
Macdonald, Douglas .
JOURNAL OF BIOMOLECULAR SCREENING, 2010, 15 (05) :478-487
[29]   A MICROTITER PLATE TRANSGLUTAMINASE ASSAY UTILIZING 5-(BIOTINAMIDO)PENTYLAMINE AS SUBSTRATE [J].
SLAUGHTER, TF ;
ACHYUTHAN, KE ;
LAI, TS ;
GREENBERG, CS .
ANALYTICAL BIOCHEMISTRY, 1992, 205 (01) :166-171
[30]   Measurement of tissue transglutaminase activity in a permeabilized cell system: Its regulation by Ca2+ and nucleotides [J].
Smethurst, PA ;
Griffin, M .
BIOCHEMICAL JOURNAL, 1996, 313 :803-808